Description
A natural metabolite formed by CYP450-mediated hydroxylation followed by catechol-O-methyltransferase (COMT) methylation of estradiol; has anticancer agent activity as an angiogenesis inhibitor via the HIF-1α pathway; levels are significantly lower in women with severe pre-eclampsia
Formal name: 2-methoxy-estra-1,3,5(10)-triene-3,17β-diol
Synonyms: 2-Hydroxyestradiol 2-methyl ether|2-ME2|NSC 659853|Panzem
Molecular weight: 302.4
CAS: 362-07-2
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cancer|Angiogenesis||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins